Yancopoulos George

Yancopoulos George is listed in filings as Bd. Co-Chair at Regeneron Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Jan 5, 2026, including 4 public disclosures. Recent filings connect the profile to Regeneron Pharmaceuticals Inc (REGN). The current snapshot covers public activity from Dec 11, 2025 to Jan 5, 2026. Reported amounts are shown as $92.5M to $22.1M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.